Follow
Sofie Isebaert
Sofie Isebaert
KU Leuven, Department of Oncology
Verified email at med.kuleuven.be
Title
Cited by
Cited by
Year
Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial
LGW Kerkmeijer, VH Groen, FJ Pos, K Haustermans, EM Monninkhof, ...
Journal of Clinical Oncology 39 (7), 787-796, 2021
3162021
Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
A Gonnissen, S Isebaert, K Haustermans
Oncotarget 6 (16), 13899, 2015
2142015
Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology
S Isebaert, L Van den Bergh, K Haustermans, S Joniau, E Lerut, ...
Journal of magnetic resonance imaging 37 (6), 1392-1401, 2013
2072013
Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer
C Draulans, UA van der Heide, K Haustermans, FJ Pos, JV van Zyp, ...
Radiotherapy and Oncology 147, 92-98, 2020
1262020
Hedgehog signaling in prostate cancer and its therapeutic implication
A Gonnissen, S Isebaert, K Haustermans
International journal of molecular sciences 14 (7), 13979-14007, 2013
1242013
Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial
EM Monninkhof, JWL Van Loon, M van Vulpen, LGW Kerkmeijer, FJ Pos, ...
Radiotherapy and Oncology 127 (1), 74-80, 2018
1202018
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement
L Van den Bergh, E Lerut, K Haustermans, CM Deroose, R Oyen, ...
Urologic Oncology: Seminars and Original Investigations 33 (3), 109. e23-109 …, 2015
1032015
Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology
S Isebaert, F De Keyzer, K Haustermans, E Lerut, T Roskams, I Roebben, ...
European journal of radiology 81 (3), e217-e222, 2012
832012
Quantitative determination of the influence of adjuvants on foliar fungicide residues
B Ryckaert, P Spanoghe, G Haesaert, B Heremans, S Isebaert, ...
Crop Protection 26 (10), 1589-1594, 2007
812007
Mycotoxin‐producing Fusarium Species Occurring in Winter Wheat in Belgium (Flanders) During 2002–2005
S Isebaert, S De Saeger, R Devreese, R Verhoeven, P Maene, ...
Journal of Phytopathology 157 (2), 108-116, 2009
772009
A systematic assessment of radiation dose enhancement by 5-Aza-2′-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma
H De Schutter, M Kimpe, S Isebaert, S Nuyts
International Journal of Radiation Oncology* Biology* Physics 73 (3), 904-912, 2009
662009
Is there an additional value of 11C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
L Van den Bergh, M Koole, S Isebaert, S Joniau, CM Deroose, R Oyen, ...
International Journal of Radiation Oncology* Biology* Physics 83 (5), 1486-1492, 2012
502012
The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo
A Gonnissen, S Isebaert, CM McKee, R Dok, K Haustermans, RJ Muschel
Oncotarget 7 (51), 84286, 2016
472016
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
K Litovkin, S Joniau, E Lerut, A Laenen, O Gevaert, M Spahn, B Kneitz, ...
Journal of cancer research and clinical oncology 140, 1849-1861, 2014
462014
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
K Litovkin, S Joniau, E Lerut, A Laenen, O Gevaert, M Spahn, B Kneitz, ...
Journal of cancer research and clinical oncology 140, 1849-1861, 2014
462014
Evaluating a decision aid for patients with localized prostate cancer in clinical practice
S Isebaert, C Van Audenhove, K Haustermans, S Junius, S Joniau, ...
Urologia internationalis 81 (4), 383-388, 2008
402008
DNA methylation-guided prediction of clinical failure in high-risk prostate cancer
K Litovkin, A Van Eynde, S Joniau, E Lerut, A Laenen, T Gevaert, ...
PLoS One 10 (6), e0130651, 2015
392015
Patterns of failure following external beam radiotherapy with or without an additional focal boost in the randomized controlled FLAME trial for localized prostate cancer
VH Groen, K Haustermans, FJ Pos, C Draulans, S Isebaert, ...
European Urology 82 (3), 252-257, 2022
382022
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus
C Draulans, R De Roover, UA van der Heide, K Haustermans, F Pos, ...
Radiotherapy and Oncology 140, 131-142, 2019
362019
Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledge
CV Dinh, P Steenbergen, G Ghobadi, H van der Poel, SW Heijmink, ...
Medical physics 44 (3), 949-961, 2017
322017
The system can't perform the operation now. Try again later.
Articles 1–20